• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

HYDERABAD: Suven Life Sciences Ltd (SLSL) has reported a substantial growth in turnover at Rs 27.1 crore and net profit at Rs 3.2 crore for the third quarter of the current fiscal ended December 2005 as compared with a turnover of Rs 13.94 crore and net profit of Rs 1.13 crore in the corresponding quarter of the previous fiscal.

This has resulted in an EPS of Rs 1.28 (Rs 0.46) on an equity of Rs 5 crore. For the nine months period, the company's turnover stood at Rs 63.46 crore (Rs 41.55 crore) and the net profit at Rs 6.21 crore (Rs 3.19 crore), yielding an EPS of Rs 2.49 (Rs 1.28).

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
BEL net rises 18 pc in Q3

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line